Samsung has recently received approval from the US Food and Drug Administration (FDA) for its Galaxy Watch to detect atrial fibrillation (AFib). AFib is a dangerous heart condition that can lead to stroke, blood clots, and other serious health issues. The watch will be able to monitor for any irregular heartbeat patterns in the background using an electrocardiogram sensor. It will then alert users if it detects any signs of AFib so they can seek medical attention as soon as possible.
The FDA’s approval marks a major milestone in wearable technology and could potentially save many lives by allowing people to accurately monitor their hearts without having to visit a doctor or hospital every time they need testing done. Samsung has also promised that all data collected by the device would remain private and secure, ensuring users’ privacy while still providing them with important information about their health status.
This new development is sure to have far-reaching implications on healthcare worldwide, making it easier than ever before for people with heart conditions like AFib to get access to accurate monitoring tools without having to leave home or wait long periods between checkups. With this new technology available now on Samsung’s Galaxy Watches, we may see more companies creating similar devices designed specifically for tracking different types of illnesses to keep us healthier than ever before!
Read more at ExtremeTech
